Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ironwood Pharma (IRWD)
NASDAQ:IRWD
Ironwood Pharma (IRWD) Ownership - Who Owns Ironwood Pharma?
228 Followers
Ironwood Pharma (IRWD) Ownership Overview
24.50% Insiders
31.99% Mutual Funds
33.75% Other Institutional Investors
9.76% Public Companies and
Individual Investors
The ownership structure of Ironwood Pharma (IRWD) stock is a mix of institutional, retail and individual investors. Approximately 65.74% of the company’s stock is owned by Institutional Investors, 24.50% is owned by Insiders and 9.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 10, 2024 | Catherine Moukheibir Director | Sold | $517694 |
| May 22, 2024 | Thomas Mccourt Ceo,director | Sold | $436136 |
| May 22, 2024 | Andrew Davis Svp, Chief Business Officer | Sold | $146576 |
| May 22, 2024 | John Minardo Clo | Sold | $112256 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $92230 | |
| Mar 31, 2024 | Bought | $113230 | |
| Mar 31, 2024 | Bought | $117907 | |
| Mar 31, 2024 | Bought | $151405 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,413,245 | Institution | 10.95% | 113,011,960 | |
| 13,615,952 | Institution | 8.57% | 88,367,528 | |
| 11,579,368 | Institution | 7.28% | 75,150,098 | |
| 10,902,066 | Institution | 6.86% | 70,754,408 | |
| 8,907,606 | Institution | 5.60% | 57,810,363 | |
| 6,145,649 | Institution | 3.87% | 39,885,262 | |
| 2,989,514 | Institution | 1.88% | 19,401,946 | |
| 2,231,916 | Insider | 1.40% | 14,485,135 | |
| 2,137,254 | Institution | 1.34% | 13,870,778 | |
| 1,978,285 | Institution | 1.24% | 12,839,070 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,579,368 | Institution | 7.28% | 75,150,098 | |
| 10,902,066 | Institution | 6.86% | 70,754,408 | |
| 2,137,254 | Institution | 1.34% | 13,870,778 | |
| 1,978,285 | Institution | 1.24% | 12,839,070 | |
| 1,609,100 | Institution | 1.01% | 10,443,059 | |
| 1,501,000 | Institution | 0.94% | 9,741,490 | |
| 1,470,694 | Institution | 0.93% | 9,544,804 | |
| 1,406,911 | Institution | 0.89% | 9,130,852 | |
| 1,274,572 | Institution | 0.80% | 8,271,972 | |
| 1,054,190 | Institution | 0.66% | 6,841,693 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,902,159 | Institution | 5.60% | 55,371,429 | |
| 9,034,078 | Institution | 5.68% | 55,198,217 | |
| 4,127,440 | Institution | 2.60% | 26,002,872 | |
| 3,899,413 | Institution | 2.45% | 24,254,349 | |
| 3,398,998 | Institution | 2.14% | 21,413,687 | |
| 3,396,556 | Institution | 2.14% | 20,752,957 | |
| 2,070,423 | Institution | 1.30% | 13,043,665 | |
| 1,931,920 | Institution | 1.22% | 12,171,096 | |
| 1,186,923 | Institution | 0.75% | 7,252,100 | |
| 1,165,342 | Institution | 0.73% | 7,120,240 |
FAQ
Who Owns Ironwood Pharma (IRWD)?
According to the latest TipRanks data, approximately 33.75% of the company's stock is held by institutional investors, 24.50% is held by insiders, and 9.76% is held by retail investors.
What percentage of Ironwood Pharma (IRWD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.75% of Ironwood Pharma (IRWD) stock is held by institutional investors.
What percentage of Ironwood Pharma (IRWD) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.76% of Ironwood Pharma (IRWD) stock is held by retail investors.
Who owns the most shares of Ironwood Pharma (IRWD)?
iShares owns the most shares of Ironwood Pharma (IRWD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.